Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dexmedetomidine on Brain Homeostasis in Brain Tumor Surgery
NCT04266665Phase 4Completed
- Start
- Mar 2020
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in Brain Injury (BI) (2 arms). Primary endpoint: Changes in S-100b protein at 24 hours. Started Mar 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Brain Injury (BI)
Beyond the preview
Go deeper on NCT04266665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04266665.